US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist

26.660
+0.060+0.23%

Close Nov 29 13:00 ET

26.660
0.0000.00%

Post 17:01 ET

11.85BMarket Cap10.50P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

22.68%703.61M

8.29%658.21M

-35.71%664.64M

39.36%2.99B

35.57%772.63M

6.44%573.52M

5.72%607.82M

124.62%1.03B

6.27%2.14B

16.32%569.93M

Net income from continuing operations

560.53%806.36M

-44.67%194.38M

-100.84%-4.27M

638.96%1.7B

217.63%717.59M

-44.61%122.08M

-28.53%351.34M

297.47%509.09M

-81.46%230.06M

-1,236.61%-610.03M

Operating gains losses

-30.08%-655.1M

21.74%-513.66M

13.00%-605.13M

-17.05%-2.54B

-31.83%-686.82M

4.19%-503.6M

-1.03%-656.35M

-46.20%-695.57M

-8.08%-2.17B

-11.41%-521M

Depreciation and amortization

----

--0

----

-75.34%5.67M

--0

Other non cash items

11.78%798.16M

11.53%667.88M

-35.15%752.35M

30.43%3.24B

19.00%769.85M

7.93%714.03M

7.29%598.84M

87.23%1.16B

8.59%2.49B

11.76%646.94M

Change In working capital

49.43%-18.72M

33.09%50.08M

31.62%-29.5M

-83.52%5.38M

92.04%47.91M

-19.51%-37.02M

-52.00%37.63M

-8.62%-43.14M

300.11%32.66M

-45.81%24.95M

-Change in receivables

50.76%-1.32M

-142.10%-1.35M

114.83%178K

-96.64%1.07M

198.97%1.74M

-632.34%-2.68M

-89.45%3.21M

-147.98%-1.2M

208.82%31.71M

-133.78%-1.75M

-Change in payables and accrued expense

71.84%-10.64M

8.92%43.65M

-1.16%-42.7M

400.96%3.76M

33.32%43.67M

-2.04%-37.78M

-13.77%40.08M

2.86%-42.21M

-111.38%-1.25M

-14.95%32.76M

-Change in other current assets

-178.60%-2.7M

148.51%2.74M

4,637.45%13.03M

-74.57%559K

141.30%2.5M

-37.93%3.44M

-485.09%-5.66M

-77.86%275K

18.36%2.2M

-359.87%-6.06M

-Change in other current liabilities

---4.06M

----

--0

----

Cash from discontinued investing activities

Operating cash flow

22.68%703.61M

8.29%658.21M

-35.71%664.64M

39.36%2.99B

35.57%772.63M

6.44%573.52M

5.72%607.82M

124.62%1.03B

6.27%2.14B

16.32%569.93M

Investing cash flow

Cash flow from continuing investing activities

-164.66%-1.19B

-1,308.06%-893.18M

84.49%-86.65M

-101.35%-2.07B

-341.16%-1B

68.38%-450.66M

-110.20%-63.43M

-5,102.47%-558.53M

44.96%-1.03B

175.18%414.74M

Net business purchase and sale

--0

-33.38%-3.98M

-94.78%-6.97M

-26.74%-12.54M

---1.99M

41.81%-3.98M

---2.99M

-17.34%-3.58M

71.61%-9.9M

--0

Net investment purchase and sale

-166.93%-1.2B

-1,298.23%-845.17M

85.34%-84.64M

-104.97%-2.09B

-341.31%-1B

68.19%-451.13M

-100.30%-60.45M

-4,161.30%-577.31M

43.90%-1.02B

176.08%414.74M

Net other investing changes

--1K

----

---14.44M

---2.04M

--0

---12.4M

----

Cash from discontinued investing activities

Investing cash flow

-164.66%-1.19B

-1,308.06%-893.18M

84.49%-86.65M

-101.35%-2.07B

-341.16%-1B

68.38%-450.66M

-110.20%-63.43M

-5,102.47%-558.53M

44.96%-1.03B

175.18%414.74M

Financing cash flow

Cash flow from continuing financing activities

76.06%-325.51M

433.32%1.16B

-0.77%-212M

-127.42%-2.15B

12.67%-231.89M

-490.86%-1.36B

-52.02%-347M

4.79%-210.37M

-345.35%-944.86M

-34.07%-265.55M

Net issuance payments of debt

--0

----

---1B

--0

---1B

----

--0

Net common stock issuance

30.74%-97.05M

----

---304.76M

---30.2M

---140.12M

----

--0

Cash dividends paid

-4.80%-94.06M

-4.79%-94.94M

-5.84%-93.81M

-7.50%-358.33M

-6.10%-89.34M

-7.09%-89.75M

-9.10%-90.61M

-7.74%-88.63M

-16.88%-333.32M

-14.40%-84.2M

Net other financing activities

-3.68%-134.4M

-14.54%-139.68M

2.91%-118.19M

20.58%-485.67M

38.04%-112.36M

11.39%-129.62M

16.02%-121.95M

12.23%-121.74M

-1.54%-611.53M

-45.70%-181.35M

Cash from discontinued financing activities

Financing cash flow

76.06%-325.51M

433.32%1.16B

-0.77%-212M

-127.42%-2.15B

12.67%-231.89M

-490.86%-1.36B

-52.02%-347M

4.79%-210.37M

-345.35%-944.86M

-34.07%-265.55M

Net cash flow

Beginning cash position

-18.80%1.76B

-57.33%843M

-72.12%477.01M

11.01%1.71B

-5.56%936.45M

3.09%2.17B

10.28%1.98B

11.01%1.71B

52.78%1.54B

-44.93%991.63M

Current changes in cash

34.13%-814.59M

366.92%921.64M

38.14%365.99M

-827.00%-1.23B

-163.89%-459.44M

-10.77%-1.24B

-37.64%197.39M

5.78%264.94M

-68.12%169.7M

376.84%719.12M

End cash Position

1.45%950.05M

-18.80%1.76B

-57.33%843M

-72.12%477.01M

-5.56%936.45M

3.09%2.17B

10.28%1.98B

11.01%1.71B

Free cash flow

22.68%703.61M

8.29%658.21M

-35.71%664.64M

39.36%2.99B

35.57%772.63M

6.44%573.52M

5.72%607.82M

124.62%1.03B

6.27%2.14B

16.32%569.93M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	22.68%703.61M	8.29%658.21M	-35.71%664.64M	39.36%2.99B	35.57%772.63M	6.44%573.52M	5.72%607.82M	124.62%1.03B	6.27%2.14B	16.32%569.93M
Net income from continuing operations	560.53%806.36M	-44.67%194.38M	-100.84%-4.27M	638.96%1.7B	217.63%717.59M	-44.61%122.08M	-28.53%351.34M	297.47%509.09M	-81.46%230.06M	-1,236.61%-610.03M
Operating gains losses	-30.08%-655.1M	21.74%-513.66M	13.00%-605.13M	-17.05%-2.54B	-31.83%-686.82M	4.19%-503.6M	-1.03%-656.35M	-46.20%-695.57M	-8.08%-2.17B	-11.41%-521M
Depreciation and amortization	----	----	----	--0	----	----	----	----	-75.34%5.67M	--0
Other non cash items	11.78%798.16M	11.53%667.88M	-35.15%752.35M	30.43%3.24B	19.00%769.85M	7.93%714.03M	7.29%598.84M	87.23%1.16B	8.59%2.49B	11.76%646.94M
Change In working capital	49.43%-18.72M	33.09%50.08M	31.62%-29.5M	-83.52%5.38M	92.04%47.91M	-19.51%-37.02M	-52.00%37.63M	-8.62%-43.14M	300.11%32.66M	-45.81%24.95M
-Change in receivables	50.76%-1.32M	-142.10%-1.35M	114.83%178K	-96.64%1.07M	198.97%1.74M	-632.34%-2.68M	-89.45%3.21M	-147.98%-1.2M	208.82%31.71M	-133.78%-1.75M
-Change in payables and accrued expense	71.84%-10.64M	8.92%43.65M	-1.16%-42.7M	400.96%3.76M	33.32%43.67M	-2.04%-37.78M	-13.77%40.08M	2.86%-42.21M	-111.38%-1.25M	-14.95%32.76M
-Change in other current assets	-178.60%-2.7M	148.51%2.74M	4,637.45%13.03M	-74.57%559K	141.30%2.5M	-37.93%3.44M	-485.09%-5.66M	-77.86%275K	18.36%2.2M	-359.87%-6.06M
-Change in other current liabilities	---4.06M	----	----	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	22.68%703.61M	8.29%658.21M	-35.71%664.64M	39.36%2.99B	35.57%772.63M	6.44%573.52M	5.72%607.82M	124.62%1.03B	6.27%2.14B	16.32%569.93M
Investing cash flow
Cash flow from continuing investing activities	-164.66%-1.19B	-1,308.06%-893.18M	84.49%-86.65M	-101.35%-2.07B	-341.16%-1B	68.38%-450.66M	-110.20%-63.43M	-5,102.47%-558.53M	44.96%-1.03B	175.18%414.74M
Net business purchase and sale	--0	-33.38%-3.98M	-94.78%-6.97M	-26.74%-12.54M	---1.99M	41.81%-3.98M	---2.99M	-17.34%-3.58M	71.61%-9.9M	--0
Net investment purchase and sale	-166.93%-1.2B	-1,298.23%-845.17M	85.34%-84.64M	-104.97%-2.09B	-341.31%-1B	68.19%-451.13M	-100.30%-60.45M	-4,161.30%-577.31M	43.90%-1.02B	176.08%414.74M
Net other investing changes	--1K	----	----	---14.44M	---2.04M	--0	--0	---12.4M	----	----
Cash from discontinued investing activities
Investing cash flow	-164.66%-1.19B	-1,308.06%-893.18M	84.49%-86.65M	-101.35%-2.07B	-341.16%-1B	68.38%-450.66M	-110.20%-63.43M	-5,102.47%-558.53M	44.96%-1.03B	175.18%414.74M
Financing cash flow
Cash flow from continuing financing activities	76.06%-325.51M	433.32%1.16B	-0.77%-212M	-127.42%-2.15B	12.67%-231.89M	-490.86%-1.36B	-52.02%-347M	4.79%-210.37M	-345.35%-944.86M	-34.07%-265.55M
Net issuance payments of debt	--0	----	----	---1B	--0	---1B	----	----	--0	--0
Net common stock issuance	30.74%-97.05M	----	----	---304.76M	---30.2M	---140.12M	----	----	--0	--0
Cash dividends paid	-4.80%-94.06M	-4.79%-94.94M	-5.84%-93.81M	-7.50%-358.33M	-6.10%-89.34M	-7.09%-89.75M	-9.10%-90.61M	-7.74%-88.63M	-16.88%-333.32M	-14.40%-84.2M
Net other financing activities	-3.68%-134.4M	-14.54%-139.68M	2.91%-118.19M	20.58%-485.67M	38.04%-112.36M	11.39%-129.62M	16.02%-121.95M	12.23%-121.74M	-1.54%-611.53M	-45.70%-181.35M
Cash from discontinued financing activities
Financing cash flow	76.06%-325.51M	433.32%1.16B	-0.77%-212M	-127.42%-2.15B	12.67%-231.89M	-490.86%-1.36B	-52.02%-347M	4.79%-210.37M	-345.35%-944.86M	-34.07%-265.55M
Net cash flow
Beginning cash position	-18.80%1.76B	-57.33%843M	-72.12%477.01M	11.01%1.71B	-5.56%936.45M	3.09%2.17B	10.28%1.98B	11.01%1.71B	52.78%1.54B	-44.93%991.63M
Current changes in cash	34.13%-814.59M	366.92%921.64M	38.14%365.99M	-827.00%-1.23B	-163.89%-459.44M	-10.77%-1.24B	-37.64%197.39M	5.78%264.94M	-68.12%169.7M	376.84%719.12M
End cash Position	1.45%950.05M	-18.80%1.76B	-57.33%843M	-72.12%477.01M	-72.12%477.01M	-5.56%936.45M	3.09%2.17B	10.28%1.98B	11.01%1.71B	11.01%1.71B
Free cash flow	22.68%703.61M	8.29%658.21M	-35.71%664.64M	39.36%2.99B	35.57%772.63M	6.44%573.52M	5.72%607.82M	124.62%1.03B	6.27%2.14B	16.32%569.93M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data